Related Experiment Video
Updated: May 1, 2026

09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
9.0K
Docetaxel-loaded redox-sensitive nanoparticles self-assembling from poly(caprolactone) conjugates with
Yongli Shi1, Chunyan Li2, Mingbo Yang1
1College of Pharmacy, Xinxiang Medical University, Xinxiang, P.R. China.
Journal of Biomaterials Science. Polymer Edition
|July 7, 2022
Summary
Novel redox-sensitive nanoparticles (NPs) were developed for improved breast cancer treatment. These drug-loaded NPs show enhanced anti-tumor activity and good biocompatibility, offering a promising therapeutic strategy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Polymer Chemistry
Background:
- Developing effective drug delivery systems is crucial for cancer therapy.
- Redox-sensitive nanoparticles offer targeted drug release in tumor microenvironments.
- Poly(caprolactone) and poly(ethylene glycol) are widely used in biomedical applications.
Purpose of the Study:
- To synthesize and characterize novel redox-sensitive nanoparticles (NPs) for drug delivery.
- To evaluate the anti-tumor efficacy of docetaxel-loaded NPs against breast cancer cells.
- To assess the biocompatibility and cellular uptake of the developed NPs.
Main Methods:
- Synthesis of DPSP polymer using ring-opening polymerization (ROP) and RAFT polymerization.
- Fabrication of DPSP NPs via solvent-evaporation method.
- In vitro evaluation of anti-tumor activity using MTT assay and cellular uptake studies.
- In vivo assessment of blood compatibility and bio-security.
Main Results:
- DPSP polymer synthesis confirmed by 1H NMR and FTIR.
- DPSP NPs exhibited a circular shape with an average diameter of 107.8 nm.
- NPs demonstrated redox-responsive behavior and enhanced cellular uptake by 4T1 cells.
- DTX-loaded DPSP NPs showed improved in vitro anti-tumor activity compared to free DTX.
- Animal studies confirmed excellent blood compatibility and bio-security.
Conclusions:
- Novel redox-sensitive DPSP NPs were successfully fabricated.
- The developed NPs exhibit promising characteristics for targeted drug delivery in cancer therapy.
- The enhanced anti-tumor activity and biocompatibility highlight the therapeutic potential of these nanoparticles.

